Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously ...

Blood clots form in response to signals from the lungs of cancer patients - not from other organ sites, as previously thought - according to a ...

and an anti‐human polyclonal antibody for CXCL13 (a chemokine for inducing migration of B cells) (R&D Systems, Minneapolis, MN). After staining, signals were visualized with 3,3′‐diaminobezidine, and ...

In particular, BCMA expressed by antibody-producing cells, and the chemokines CXCL13 and CCL21, markers of immune infiltration of glandular tissues were further downregulated at 50 mg and 300 mg doses ...

We also validated the differential effects of ICI (using a PD-1 antibody) and MAPKi on CXCL13 expression by activated T cells, albeit in an in vitro context. Another limitation is that the use of ...

Primary antibodies used include decorin (1:50 ... Abcam), CD19 (1:50, ab134114, Abcam), CXCL13 (1:100, PA5-47035, Invitrogen, Waltham, MA, USA), and CD31 (1:50, ab9498, Abcam). Next-day samples were ...